Have a personal or library account? Click to login
Value of ultrasound assessment of sarcopenia in patients with diffuse large B-cell lymphoma: a prospective study Cover

Value of ultrasound assessment of sarcopenia in patients with diffuse large B-cell lymphoma: a prospective study

Open Access
|Jul 2025

Figures & Tables

Figure 1.

Participant flow chart for study. A total of 167 cases were eventually recruited into the sarcopenia (n = 88) and non-sarcopenia (n = 79) groups for analysis.
Participant flow chart for study. A total of 167 cases were eventually recruited into the sarcopenia (n = 88) and non-sarcopenia (n = 79) groups for analysis.

Figure 2.

Muscle thickness and cross-sectional area of the extremity muscles. (A) Muscle thickness of biceps brachii (BB) and brachialis, cross-sectional area of BB; (B) Muscle thickness of radial anterior (RA) muscle and ulnar anterior (UA) muscle; (C) Muscle thickness and cross-sectional area of rectus femoris (RF), muscle thickness of vastus intermedius (VI); (D) Muscle thickness of tibialis posterior (TP) and fibula posterior (FP).
Muscle thickness and cross-sectional area of the extremity muscles. (A) Muscle thickness of biceps brachii (BB) and brachialis, cross-sectional area of BB; (B) Muscle thickness of radial anterior (RA) muscle and ulnar anterior (UA) muscle; (C) Muscle thickness and cross-sectional area of rectus femoris (RF), muscle thickness of vastus intermedius (VI); (D) Muscle thickness of tibialis posterior (TP) and fibula posterior (FP).

Figure 3.

ROC analysis for the prediction of sarcopenia from extremity muscle thickness and cross-sectional area. (A) The predictive value of extremity muscle thickness. (B) The predictive value of extremity muscle cross-sectional area.
BB = biceps brachii; CSA = cross-sectional area; MT = muscle thickness; PP = psoas posterior; RA = radial anterior; RF = rectus femoris; QF = quadriceps femoris; TP = tibialis posterior; UA = ulnar anterior; VI = vastus intermedius
ROC analysis for the prediction of sarcopenia from extremity muscle thickness and cross-sectional area. (A) The predictive value of extremity muscle thickness. (B) The predictive value of extremity muscle cross-sectional area. BB = biceps brachii; CSA = cross-sectional area; MT = muscle thickness; PP = psoas posterior; RA = radial anterior; RF = rectus femoris; QF = quadriceps femoris; TP = tibialis posterior; UA = ulnar anterior; VI = vastus intermedius

Patient clinical characteristics at diagnosis and comparison between patients with or without sarcopenia

Total (n = 167)Sarcopenia (n = 88)No sarcopenia (n = 79)P value
Age (years)60 ± 14.1563 ± 14.7056 ± 12.650.002
Gender, n (%) < 0.001
Males98 (59)40 (46)58 (73)
Females69 (41)48 (54)21 (27)
Height (cm)166.63 ± 8.55164.69 ± 8.42168.78 ± 8.230.002
Weight (kg)66.24 ± 11.7661.33 ± 10.6171.71 ± 10.54< 0.001
BMI (kg/m2)23.79 ± 3.1722.60 ± 3.0825.12 ± 2.74< 0.001
CC (cm)33.50 ± 3.2532.00 ± 2.6935.18 ± 3.00< 0.001
Handgrip strength (kg)23.19 ± 10.0018.50 ± 7.5128.41 ± 9.88< 0.001
Gait speed (m/s)1.02 ± 0.290.92 ± 0.241.14 ± 0.29< 0.001
SMA (cm2)116.71 ± 27.8998.86 ± 18.26136.59 ± 22.89< 0.001
SMI (cm2/m2)41.63 ± 7.5736.21 ± 4.7347.67 ± 5.17< 0.001
Upper arm SFT (cm)0.30 ± 0.160.29 ± 0.140.32 ± 0.180.23
BB and brachialis MT (cm)2.29 ± 0.462.02 ± 0.382.59 ± 0.34< 0.001
BB CSA (cm2)8.24 ± 2.686.67 ± 2.119.99 ± 2.10< 0.001
Forearm SFT (cm)0.36 ± 0.150.35 ± 0.170.37 ± 0.140.498
UA MT (cm)3.55 ± 0.493.34 ± 0.463.79 ± 0.41< 0.001
RA MT (cm)1.63 ± 0.361.48 ± 0.321.79 ± 0.33< 0.001
Thigh SFT (cm)0.78 ± 0.360.78 ± 0.370.78 ± 0.350.989
RF MT (cm)1.54 ± 0.331.36 ± 0.301.74 ± 0.23< 0.001
VI MT (cm)1.45 ± 0.411.22 ± 0.341.71 ± 0.33< 0.001
QF MT (cm)2.99 ± 0.702.58 ± 0.593.45 ± 0.51< 0.001
RF CSA (cm2)7.12 ± 1.936.01 ± 1.568.36 ± 1.51< 0.001
Lower leg SFT (cm)0.45 ± 0.190.45 ± 0.170.45 ± 0.210.844
TP MT (cm)4.87 ± 0.744.49 ± 0.625.28 ± 0.63< 0.001
FP MT (cm)2.39 ± 0.712.10 ± 0.612.72 ± 0.67< 0.001

ROC analysis results for the prediction of sarcopenia from ultrasonographically measured muscle thickness and cross-sectional area

AUC(95%CI)Cut-offSpecificitySensitivityAccuracy
BB and brachialis MT (cm)86.87% (81.28% ~ 92.47%)2.220.770.900.83
BB CSA(cm2)86.82% (81.41% ~ 92.23%)7.460.690.920.80
UA MT(cm)77.13% (70.04% ~ 84.22%)3.550.730.720.72
RA MT(cm)77.44% (70.14% ~ 84.73%)1.560.690.780.74
RF MT(cm)85.34% (79.56% ~ 91.12%)1.580.780.810.80
VI MT(cm)84.07% (78.24% ~ 89.9%)1.380.670.890.77
QF MT(cm)87.46% (82.17% ~ 92.75%)2.920.740.870.80
RF CSA(cm2)87.59% (82.16% ~ 93.02%)7.080.830.860.84
TP MT(cm)81.77% (75.42% ~ 88.12%)4.900.800.720.76
FP MT(cm)75.75% (68.44% ~ 83.06%)2.200.680.730.71

Odds ratios and 95% confidence intervals for the prediction of sarcopenia from ultrasound parameters

Non-adjustedModel IModel II
OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P value
BB and brachialis MT28.32 (11.74~68.27)< 0.001107.93 (12.01–970.38)< 0.001126.27 (12.06–1321.54)< 0.001
BB CSA26.07 (10.13–67.11)< 0.00120.56 (5.85–72.29)< 0.00116.55 (4.5–60.85)< 0.001
UA MT6.91 (3.5–13.63)< 0.0013.42 (1.42–8.22)0.0062.7 (1.04–6.99)0.041
RA MT7.42 (3.7–14.89)< 0.0013.74 (1.65–8.46)0.0023.17 (1.35–7.45)0.008
RF MT15.49 (7.26–33.05)< 0.0018.19 (3.55–18.93)< 0.0016.28 (2.64–14.98)< 0.001
VI MT13.61 (6–30.87)< 0.00110.68 (4.13–27.58)< 0.0019.52 (3.47–26.12)< 0.001
QF MT19.5 (8.62–44.1)< 0.00113.04 (5.25–32.38)< 0.00111.08 (4.23–29.04)< 0.001
RF CSA30.08 (12.92–70.05)< 0.00115.06 (6.03–37.6)< 0.00113.26 (5.11–34.43)< 0.001
TP MT9.41 (4.64–19.08)< 0.0014.58 (2–10.45)< 0.0013.65 (1.53–8.73)0.004
PP MT5.62 (2.88–10.96)< 0.0013.72 (1.66–8.34)0.0012.85 (1.23–6.6)0.014
DOI: https://doi.org/10.2478/raon-2025-0036 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 301 - 310
Submitted on: Dec 18, 2024
|
Accepted on: Apr 11, 2025
|
Published on: Jul 8, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Teng Liu, Junjun Wan, Yangyang Liu, Jing Zhuo, Weijiang Fu, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.